Related references
Note: Only part of the references are listed.Tafamidis-A Pricey Therapy for a Not-So-Rare Condition
Jerry H. Gurwitz et al.
JAMA CARDIOLOGY (2020)
Updated Cost-effectiveness Analysis of Evolocumab in Patients With Very High-risk Atherosclerotic Cardiovascular Disease
Gregg C. Fonarow et al.
JAMA CARDIOLOGY (2019)
Association of Medicaid Expansion With Cardiovascular Mortality
Sameed Ahmed M. Khatana et al.
JAMA CARDIOLOGY (2019)
Health Care Spending in the United States and Other High-Income Countries
Irene Papanicolas et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Discounting in Economic Evaluations
Arthur E. Attema et al.
PHARMACOECONOMICS (2018)
Reassessing the Role of Surrogate End Points in Drug Development for Heart Failure
Stephen J. Greene et al.
CIRCULATION (2018)
Comparative cost-effectiveness of surgery, angioplasty, or medical therapy in patients with multivessel coronary artery disease: MASS II trial
Sara Michelly Goncalves Brandao et al.
COST EFFECTIVENESS AND RESOURCE ALLOCATION (2018)
Factors Associated With Increases in US Health Care Spending, 1996-2013
Joseph L. Dieleman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses Second Panel on Cost-Effectiveness in Health and Medicine
Gillian D. Sanders et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Principles of pharmacoeconomics and their impact on strategic imperatives of pharmaceutical research and development
Jozsef Bodrogi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Health outcomes in economic evaluation: the QALY and utilities
Sarah J. Whitehead et al.
BRITISH MEDICAL BULLETIN (2010)
Health Economic Assessment: Cost-Effectiveness Thresholds and Other Decision Criteria Reply
Steven Simoens
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2010)
EQUIVALENCE OF TWO HEALTHCARE COSTING METHODS: BOTTOM-UP AND TOP-DOWN
Michael K. Chapko et al.
HEALTH ECONOMICS (2009)
Comparing methodologies for the cost estimation of hospital services
S. S. Tan et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2009)
Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility
A Manca et al.
HEALTH ECONOMICS (2005)
Cost-effectiveness acceptability curves - facts, fallacies and frequently asked questions
E Fenwick et al.
HEALTH ECONOMICS (2004)
Calculation of quality adjusted life years in the published literature: a review of methodology and transparency
G Richardson et al.
HEALTH ECONOMICS (2004)
Health technology assessment: history and demand
A Stevens et al.
JOURNAL OF PUBLIC HEALTH MEDICINE (2003)
Introduction to health economics for physicians
MI Meltzer
LANCET (2001)
Stochastic league tables: Communicating cost-effectiveness results to decision-makers
RCW Hutubessy et al.
HEALTH ECONOMICS (2001)
Share Paper
